TrialInvestigational new drugs2014

Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer.

Anita Schwandt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.